The genetic alteration rate of HSD17B1 was detected only in 6% of the BLCA patients, in which the most frequent mutation resulting to increase in HSD17B1 mRNA levels (Fig. 3A and 3B). The gene discussed is HSD17B1; the disease is bladder transitional cell carcinoma.